Company / Interest Expense
PUMA BIOTECHNOLOGY, INC. Interest Expense History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$12.8M
FY2023
5-year range
$12.8M / $15.0M
FY2019-FY2023
Trend
-8.8%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $15M to $13M over the past 2 years.
Based on SEC 10-K filings.
$13M in FY2023 with a 5-year CAGR of +77.8%.
Improved from $15M to $13M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +5.2%
- 5-Year CAGR
- +77.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +77.8%, indicating consistent growth.
- In FY2023, interest expense decreased 8.8% year-over-year.
- Peak interest expense was recorded in FY2021.
- Lowest interest expense in the period was in FY2019.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $12.8M | -8.8% |
| FY2022 | $14.0M | -6.5% |
| FY2021 | $15.0M | +36.7% |
| FY2020 | $11.0M | +1425.7% |
| FY2019 | $720.0K | +0.0% |
| FY2018 | $720.0K | +0.0% |
| FY2017 | $720.0K | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026